吴琳琳;刘捷宸;邵慧勇;孙晓冬;

• 1:上海市疾病预防控制中心

摘要(Abstract)：

目的评价上海市无细胞百白破b型流感嗜血杆菌联合疫苗(DTaP-Hib)单独接种及与其他疫苗同时接种的安全性。方法通过中国疑似预防接种异常反应(AEFI)信息管理系统收集2014-2017年上海市报告的DTaP-Hib AEFI病例,对数据进行描述性分析。结果 2014-2017年上海市共报告DTaP-Hib AEFI 2 665例,报告发生率为603.41/10万;DTaP-Hib单独、同时接种的AEFI报告发生率分别为749.69/10万、477.74/10万,一般反应报告发生率分别为743.32/10万、468.06/10万,异常反应报告发生率分别为6.37/10万、8.84/10万。结论 DTaP-Hib与其他疫苗同时接种未增加AEFI的发生率。

关键词(KeyWords)： 无细胞百白破b型流感嗜血杆菌联合疫苗;疑似预防接种异常反应;同时接种;安全性

Abstract:

Keywords:

基金项目(Foundation): 上海市第四轮公共卫生三年行动计划重点学科建设项目-传染病与卫生微生物学(15GWZK0101)

作者(Authors): 吴琳琳;刘捷宸;邵慧勇;孙晓冬;

参考文献(References)：

• [1]韦宁,安志杰,郑景山,等.减毒活疫苗同时接种建议的分析[J].中国疫苗和免疫,2014,20(5):459-464,472.WEI Ning,AN Zhijie,ZHENG Jingshan,et al.Recommendations for simultaneous administration of attenuated live vaccines[J].Chinese Journal of Vaccines and Immunization,2014,20(5):459-464,472.
• [2]潘会明,严毅,王蕾.关于计免疫苗同时接种及其相关问题的探讨和建议[J].中国初级卫生保健2013,27(12):73-75.PAN Huiming,YAN Yi,WANG Lei.Discussion and suggestion on EPI vaccination at the same time and related problems[J].Chinese Primary Health Care,2013,27(12):73-75.
• [3]卫生部办公厅,国家食品药品监督管理局办公室.全国疑似预防接种异常反应监测方案[S].2010-06-03.General Office of Ministry of Health,General Office of State Food and Drug Administration.National guideline for surveillance of adverse events following immunization[S].2010-06-03.
• [4]STANLEY A,WALTER A,PAUL AO.Vaccines[M].6th ed.New York:Elsevier/Saunder,2012:981-1007.
• [5]叶家楷,李克莉,许涤沙,等.中国2015年疑似预防接种异常反应监测分析[J].中国疫苗和免疫,2017,23(5):481-492,511.YE Jiakai,WU Wendi,XU Disha,et al.Surveillance of adverse events following immunization in China,2015[J].Chinese Journal of Vaccines and Immunization,2017,23(5):481-492,511.
• [6]World Health Organization Regional Office for the Western Pacific.Immunization safety surveillance:guidelines for immunization programme managers on surveillance of adverse events following immunization(second edition)[S].2013.
• [7]刘大卫,郭飚,曹玲生,等.吸附无细胞和全细胞百白破联合疫苗上市后预防接种安全性的比较分析[J].中国疫苗和免疫,2008,14(2):97-102.LIU Dawei,GUO Biao,CAO Lingsheng,et al.Comparative study on post-marketing immunization safety of absorbed diphtheria,tetanus and acellular pertussis combined vaccine,and absorbed diphtheria,tetanus and whole-cell pertussis combined vaccine in China[J].Chinese Journal of Vaccines and Immunization,2008,14(2):97-102.
• [8]刘捷宸,邵慧勇,任佳,等.上海市2011-2015年含无细胞百日咳、白喉和破伤风成分联合疫苗预防接种安全性评价[J].中国疫苗和免疫,2016,22(2):197-201.LIU Jiechen,SHAO Huiyong,REN Jia,et al.Evaluation of the safety of diphtheria,tetanus and acellular pertussis containing combination vaccines in Shanghai,2011-2015[J].Chinese Journal of Vaccines and Immunization,2016,22(2):197-201.
• [9]庞红,吴美华.两种注射用第一类疫苗同时接种的安全性[J].中国生物制品学杂志,2009,22(5):493-495.PANG Hong,WU Meihua.Safety of simultaneous inoculation with two kinds of vaccines included in national immunization program[J].Chinese Journal of Biologicals,2009,22(5):493-495.